173 related articles for article (PubMed ID: 15944551)
21. Serum ghrelin levels in papillary thyroid carcinoma.
Ucan B; Sahin M; Kizilgul M; Ozbek M; Ozdemir S; Calıskan M; Cakal E
Arch Endocrinol Metab; 2017; 61(5):464-469. PubMed ID: 28977162
[TBL] [Abstract][Full Text] [Related]
22. PDGFRα Regulates Follicular Cell Differentiation Driving Treatment Resistance and Disease Recurrence in Papillary Thyroid Cancer.
Lopez-Campistrous A; Adewuyi EE; Benesch MGK; Ko YM; Lai R; Thiesen A; Dewald J; Wang P; Chu K; Ghosh S; Williams DC; Vos LJ; Brindley DN; McMullen TPW
EBioMedicine; 2016 Oct; 12():86-97. PubMed ID: 27682510
[TBL] [Abstract][Full Text] [Related]
23. Case Report: Papillary thyroid carcinoma in Goltz-Gorlin syndrome.
Costanza F; Papi G; Corrado S; Pontecorvi A
Front Endocrinol (Lausanne); 2023; 14():1243540. PubMed ID: 37859990
[TBL] [Abstract][Full Text] [Related]
24. Incidental Solitary Adrenal Metastasis as the Initial Manifestation of a Solid Variant of Papillary Thyroid Carcinoma, With Emphasis on Pathologic Diagnosis and Clinical Management.
Karalis JD; Jia L; Murvelashvili N; Vora A; Tessnow A; Dackiw APB
AACE Clin Case Rep; 2022; 8(3):131-134. PubMed ID: 35602883
[TBL] [Abstract][Full Text] [Related]
25. Significant dysregulation of lipid metabolism in patients with papillary thyroid carcinoma after thyroidectomy.
Zhou L; Li S; Wu Y; Chen Q; Hu X; Jiang J; Shi Y; Shen D; Xie L
Front Endocrinol (Lausanne); 2023; 14():1223527. PubMed ID: 37900134
[TBL] [Abstract][Full Text] [Related]
26. Diffuse sclerosing variant papillary thyroid carcinoma has worse survival than classic papillary thyroid carcinoma: a meta-analysis.
Crayton H; Wu K; Leong D; Bhimani N; Gild M; Glover A
Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36952650
[TBL] [Abstract][Full Text] [Related]
27. Clinical responses to vemurafenib in postoperative recurrence of papillary thyroid carcinoma with esophageal fistula: A case report.
He S; Lu W; Ding X; Zhou J; Liu D; Zhu Y; Yang F; Fu Z
Medicine (Baltimore); 2024 Mar; 103(11):e37513. PubMed ID: 38489728
[TBL] [Abstract][Full Text] [Related]
28. Management of pediatric papillary thyroid cancer.
Pazaitou-Panayiotou K
Hell J Nucl Med; 2023; 26 Suppl():60-64. PubMed ID: 37658567
[TBL] [Abstract][Full Text] [Related]
29. Recurrence and survival for patients with thyroid carcinoma in the pediatric age group in the Emirate of Abu Dhabi: retrospective analysis of a multicentre cohort.
Ben Ghashir N; Elomami A; Al Masoud R; Caponio VCA; Al Seddeeqi E
J Pediatr Endocrinol Metab; 2024 Jan; 37(1):52-61. PubMed ID: 38015567
[TBL] [Abstract][Full Text] [Related]
30. Management of aggressive variants of papillary thyroid cancer.
Lee YK; Rovira A; Carroll PV; Simo R
Curr Opin Otolaryngol Head Neck Surg; 2024 Apr; 32(2):125-133. PubMed ID: 38116795
[TBL] [Abstract][Full Text] [Related]
31. Identification of key candidate genes and pathways in follicular variant papillary thyroid carcinoma by integrated bioinformatical analysis.
Jing L; Xia F; Du X; Jiang B; Chen Y; Li X
Transl Cancer Res; 2020 Feb; 9(2):477-490. PubMed ID: 35117392
[TBL] [Abstract][Full Text] [Related]
32. Rare distant metastases to pancreas, liver, and lung as initial presentation of mixed tall cell and columnar cell variants of papillary thyroid cancer.
Harper C; Michael J; Rahmeh T; Munro V
Endocrinol Diabetes Metab Case Rep; 2022 Nov; 2022():. PubMed ID: 36511454
[TBL] [Abstract][Full Text] [Related]
33. Thyroid collision tumor containing oncocytic carcinoma, classical and hobnail variants of papillary carcinoma and areas of poorly differentiated carcinoma.
Toyoshima MTK; Domingues RB; Soares IC; Danilovic DLS; Amorim LC; Cavalcante ERC; Antonacio FF; Roitberg FSR; Hoff AO
Arch Endocrinol Metab; 2021 Nov; 65(4):495-499. PubMed ID: 34283905
[TBL] [Abstract][Full Text] [Related]
34. The expression of two immunosuppressive SIGLEC family molecules in papillary thyroid cancer and their effect on prognosis.
Jin T; Wang W; Ge L; Li X; Ge M
Endocrine; 2023 Dec; 82(3):590-601. PubMed ID: 37480496
[TBL] [Abstract][Full Text] [Related]
35. Can New Ultrasound Signs Help in Identifying Follicular Variant of Papillary Carcinoma of Thyroid? - A Pilot Study.
Anuradha C; Manipadam MT; Asha HS; Dukhabandhu N; Abraham D; Paul MJ
Ultrasound Int Open; 2016 May; 2(2):E47-53. PubMed ID: 27689170
[TBL] [Abstract][Full Text] [Related]
36. Papillary Thyroid Cancer Trends in the Wake of the COVID-19 Pandemic: Is There a Shift toward a More Aggressive Entity?
Hassan I; Hassan L; Bacha F; Al Salameh M; Gatee O; Hassan W
Diseases; 2024 Mar; 12(3):. PubMed ID: 38534986
[TBL] [Abstract][Full Text] [Related]
37. Exploring the clinical utility of angioinvasion markers in papillary thyroid cancer: a literature review.
Buczyńska A; Kościuszko M; Krętowski AJ; Popławska-Kita A
Front Endocrinol (Lausanne); 2023; 14():1261860. PubMed ID: 38089632
[TBL] [Abstract][Full Text] [Related]
38. The intratumor microbiome predicts prognosis across gender and subtypes in papillary thyroid carcinoma.
Gnanasekar A; Castaneda G; Iyangar A; Magesh S; Perez D; Chakladar J; Li WT; Bouvet M; Chang EY; Ongkeko WM
Comput Struct Biotechnol J; 2021; 19():1986-1997. PubMed ID: 33995898
[TBL] [Abstract][Full Text] [Related]
39. Papillary thyroid carcinoma in a 5-year old child, mimicking lymphoma in presentation.
Aladily TN; Khader M; Bustami N; Samara OA
Avicenna J Med; 2021; 11(2):103-106. PubMed ID: 33996648
[TBL] [Abstract][Full Text] [Related]
40. Excess iodine from an unexpected source.
Arum SM; He X; Braverman LE
N Engl J Med; 2009 Jan; 360(4):424-6. PubMed ID: 19164199
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
